Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploiting common genetic variation to make anticoagulation safer.

Stroke - 1 Mar 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases
Share to Blood Coagulation
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracranial Hemorrhages

Share to Mixed Function Oxygenases

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 19150865
DOI: 10.1161/STROKEAHA.108.533190
PMCID: PMC6372103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploiting common genetic variation to make anticoagulation safer.PMID 19150865Read ↗

Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.Semantic proximity Read ↗

Making anticoagulation safer.Semantic proximity Read ↗

Genetics of warfarin dosing--one polymorphism at a time.Semantic proximity Read ↗

Genetic susceptibility to hemorrhagic complications during warfarin therapy.Semantic proximity Read ↗

Genetics of atrial fibrillation: implications for future research directions and personalized medicine.Semantic proximity Read ↗

Pharmacogenetics of warfarin: challenges and opportunitiesSemantic proximity Read ↗

Using genetic testing to guide warfarin therapy.Semantic proximity Read ↗

Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.Semantic proximity Read ↗

Pharmacogenomic considerations for customizing warfarin therapy in the orthopedic patient.Semantic proximity Read ↗

Anticoagulation therapy: Warfarin dosing--novel SNP identified.Semantic proximity Read ↗

Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice.Semantic proximity Read ↗

Genetics of atrial fibrillation: rare mutations, common polymorphisms, and clinical relevance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.